Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells

AIM: To evaluate the safety and clinical efficacy of a new immunotherapy using both α-Gal epitope-pulsed dendritic cells (DCs) and cytokine-induced killer cells. METHODS: Freshly collected hepatocellular carcinoma (HCC) tumor tissues were incubated with a mixture of neuraminidase and recombinant α1,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Qiu, Ying, Xu, Ming-Bao, Yun, Mark M, Wang, Yi-Zhong, Zhang, Rui-Ming, Meng, Xing-Kai, Ou-Yang, Xiao-Hui, Yun, Sheng
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3247689/
https://ncbi.nlm.nih.gov/pubmed/22219594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i48.5260
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados